Primary Care Physicians
Primary Care, PrEP, Preexposure Prophylaxsis, Sexual health, Sexually transmitted infection, Communication, Sexual behavior
Charlene A. Flash, MD, MPH
Charlene A. Flash, MD, MPH
Associate Chief Medical Officer
Legacy Community Health
Clinical Assistant Professor of Medicine
Section of Infectious Diseases
Baylor College of Medicine
Dr. Charlene Flash is the Associate Chief Medical Officer for Legacy Community Health, the largest Federally Qualified Health Center in Houston, TX. A highly sought-after national expert on the implementation of HIV pre-exposure prophylaxis, Dr. Flash developed one of the first comprehensive HIV prevention programs in the United States to prescribe HIV pre-exposure prophylaxis (PrEP) to high-risk heterosexuals and men who have sex with men (MSM) in a real-world setting outside the context of a demonstration project or clinical trial. Dr. Flash served as the Assistant Medical Director of HIV Prevention Services for Harris Health System and provided primary care to a large panel of patients with HIV at Thomas Street Health Center. Dr. Flash complements her administrative and clinical engagement with research on HIV testing, prevention and treatment, health care disparities and implementation science. She maintains a voluntary clinical faculty appointment at Baylor College of Medicine as an Assistant Professor of Medicine in the Division of Infectious Disease. Dr. Flash is a graduate of Yale University and of Rutgers Robert Wood Johnson Medical School. Dr. Flash received her master’s in public health from Rutgers School of Public Health. Dr. Flash completed Medicine-Pediatrics residency at Brown University and adult infectious disease fellowship at Harvard - Beth Israel Deaconess Medical Center.
|1.||Utilize US Public Health Service (USPHS)/US Centers for Disease Control and Prevention (CDC) clinical practice guidelines: Preexposure Prophylaxis for the Prevention of HIV infection in the United States to appropriately screen and determine eligibility for PrEP||2.||Initiate a patient-provider dialog regarding sexual health and conduct a sexual behavior assessment |
|3.||Implement appropriate HIV-prevention strategies for initiation and monitoring of patients on PrEP||4.||Demonstrate understanding of the burden and epidemiology surrounding HIV risk and transmission|
|1.||Utilize US Public Health Service (USPHS)/US Centers for Disease Control and Prevention (CDC) clinical practice guidelines: Preexposure Prophylaxis for the Prevention of HIV infection in the United States to appropriately screen and determine eligibility for PrEP|
|2.||Initiate a patient-provider dialog regarding sexual health and conduct a sexual behavior assessment |
|3.||Implement appropriate HIV-prevention strategies for initiation and monitoring of patients on PrEP|
|4.||Demonstrate understanding of the burden and epidemiology surrounding HIV risk and transmission|
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the National Association for Continuing Education (NACE) and Integritas Communications. NACE is accredited by the ACCME to provide continuing medical education for physicians.
The National Association for Continuing Education designates this live activity for a maximum of 0.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
The National Association for Continuing Education is approved as a provider of nurse practitioner continuing education by the American Association of Nurse Practitioners. AANP Provider Number 121222. This program has been approved for 0.5 contact hours of continuing education.
Policy on Faculty and Provider Disclosure
It is the policy of The National Association for Continuing Education to ensure fair balance, independence, objectivity and scientific rigor in all activities. All faculty participating in CME activities sponsored by The National Association for Continuing Education are required to present evidence-based data, identify and reference off-label product use, and disclose all relevant financial relationships. Faculty disclosure information is provided below.
Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed in this activity should not be used by clinicians without evaluation of patient conditions and possible contraindications on dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.
Instructions to Receive Credit
In order to receive credit for this activity, the participant must complete the program evaluation.
Fee Information & Refund/Cancellation Policy
There is no fee for this educational activity.
|Supported Browsers: |
Internet Explorer 8.0+ for Windows 2000, 2003, Vista, XP, Windows 7, Windows 8 and above
Google Chrome 28.0+ for Windows, Mac OS, or Linux
Mozilla Firefox 23.0+ for Windows, Mac OS, or Linux
Safari 6+ for Mac OSX 10.7 and above
For video playback, install the latest version of Flash or Quicktime.
|Supported Phones & Tablets: |
Android 4.0.3 and above
iPhone/iPad with iOS 6.1 or above
This activity is supported by an independent educational grant from Gilead Sciences, Inc.